We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,884
Increased
5,796
Reduced
5,769
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFMD
12826
CALL
DELISTED
Affimed
AFMD
$95K ﹤0.01%
1,530
-17,110
-92% -$1.13M
BKD icon
12827
CALL
Brookdale Senior Living
BKD
$3.49B
$95K ﹤0.01%
15,100
-40,100
-73% -$286K
CAPR icon
12828
CALL
Capricor Therapeutics
CAPR
$223M
$95K ﹤0.01%
23,700
-33,900
-59% -$154K
CMCM
12829
CALL
Cheetah Mobile
CMCM
$86.6M
$95K ﹤0.01%
11,640
-1,120
-9% -$11K
GALT icon
12830
Galectin Therapeutics
GALT
$196M
$95K ﹤0.01%
+24,432
New +$82.8K
GTBP icon
12831
GT Biopharma
GTBP
$10.6M
$95K ﹤0.01%
471
-16,531
-97% -$4.98M
KMDA icon
12832
CALL
Kamada
KMDA
$412M
$95K ﹤0.01%
+18,000
New +$98.4K
RYAM icon
12833
CALL
Rayonier Advanced Materials
RYAM
$604M
$95K ﹤0.01%
12,600
-700
-5% -$4.82K
NTRP icon
12834
CALL
NextTrip
NTRP
$24.2M
$95K ﹤0.01%
1,560
-395
-20% -$27.1K
IGC icon
12835
IGC Pharma
IGC
$26M
$94K ﹤0.01%
63,619
-14,017
-18% -$22.7K
KULR icon
12836
KULR Technology Group
KULR
$123M
$94K ﹤0.01%
5,659
+921
+19% +$16.3K
NL icon
12837
CALL
NLI Holdings
NL
$281M
$94K ﹤0.01%
+16,400
New +$103K
FRXB.WS
12838
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$94K ﹤0.01%
108,543
-131
-0.1% -$143
ACER
12839
DELISTED
Acer Therapeutics Inc
ACER
$94K ﹤0.01%
+36,681
New +$93.1K
APEN
12840
PUT
DELISTED
Apollo Endosurgery, Inc.
APEN
$94K ﹤0.01%
10,400
-2,200
-17% -$18.9K
BHR
12841
CALL
Braemar Hotels & Resorts
BHR
$156M
$93K ﹤0.01%
19,100
-7,100
-27% -$37.1K
CCLD icon
12842
CareCloud
CCLD
$104M
$93K ﹤0.01%
12,256
-8,246
-40% -$66.8K
FTFT icon
12843
PUT
Future FinTech Group
FTFT
$1.91M
$93K ﹤0.01%
56
-73
-57% -$147K
PLX icon
12844
PUT
Protalix BioTherapeutics
PLX
$191M
$93K ﹤0.01%
69,800
-61,200
-47% -$93K
RCMT icon
12845
CALL
RCM Technologies
RCMT
$201M
$93K ﹤0.01%
+15,300
New +$77.4K
TGS icon
12846
PUT
Transportadora de Gas del Sur
TGS
$4.79B
$93K ﹤0.01%
18,800
SCPX
12847
PUT
DELISTED
Scorpius Holdings, Inc.
SCPX
$93K ﹤0.01%
4
-7
-64% -$180K
WLMS
12848
DELISTED
Williams Industrial Services Group Inc.
WLMS
$93K ﹤0.01%
21,650
+7,453
+52% +$36.3K
BGRY
12849
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$93K ﹤0.01%
+13,288
New +$114K
OBCI
12850
DELISTED
Ocean Bio-Chem Inc
OBCI
$93K ﹤0.01%
+10,000
New +$105K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.